Medtronic, Inc. (MDT) PT Raised to $165 at Argus
- Wall Street mints big gains to end strong week
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
- U.S. Supreme Court overturns Roe v. Wade, ends constitutional right to abortion
- FedEx (FDX) Gains on Solid FY23 Outlook, Analysts Mostly Bulled Up Into Next Week's Investors Day
- Get Ready for a 10% Rally in S&P 500
Argus analyst David Toung raised the price target on Medtronic, Inc. (NYSE: MDT) to $165.00 (from $150.00) while maintaining a Buy rating.
You May Also Be Interested In
- Commerzbank AG (CBK:GR) (CRZBY) PT Raised to EUR12 at Goldman Sachs
- EasyJet Plc. (EZJ:LN) (ESYJY) PT Lowered to GBP7.10 at Goldman Sachs
- Macquarie Downgrades NRW Holdings Ltd. (NWH:AU) to Neutral
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!